Results 41 to 50 of about 2,270 (113)

The effectiveness of pharmacological and lifestyle interventions to reduce the risk of diabetes and hyperglycaemia following gestational diabetes: A systematic review and meta‐analysis

Diabetic Medicine, Volume 41, Issue 6, June 2024.
Abstract Aims To synthesize the available evidence to better understand the effectiveness of interventions to prevent or delay hyperglycaemia and Type 2 diabetes mellitus (T2DM) postnatally in women with current or previous gestational diabetes mellitus (GDM).
Rebecca A. Dennison, Clare Oliver‐Williams, Helen Lin Jia Qi, Deeya Kotecha, Lydia Seed, Rebecca J. Ward, Simon J. Griffin   +6 more
wiley   +1 more source

Quality of life improvements in women with uterine fibroids treated with relugolix combination therapy during the LIBERTY long‐term extension study: A descriptive subgroup analysis in women with anemia at baseline

International Journal of Gynecology &Obstetrics, Volume 165, Issue 2, Page 431-441, May 2024.
Abstract Objective To investigate the effects of 52 weeks of treatment with relugolix combination therapy (relugolix 40 mg, estradiol 1 mg, norethindrone acetate 0.5 mg) on symptoms of uterine fibroids (UF) and quality of life (QoL) in women with heavy menstrual bleeding associated with UF and anemia (hemoglobin ≤10.5 g/dL) at baseline.
Roberta Venturella, Andrea S. Lukes, Rui Wu, Rachel McLean, Viatcheslav G. Rakov, Ayman Al‐Hendy   +5 more
wiley   +1 more source

GnRH agonist and antagonist: Options for endometriosis pain treatment [PDF]

, 2006
Basic science research into the mechanism of the development of endometriosis, its persistence and resulting pain has begun to improve our understanding of how various therapeutic options work.
Batzer, Frances R.
core   +1 more source

Consensus recommendations for the use of novel antiretrovirals in persons with HIV who are heavily treatment‐experienced and/or have multidrug‐resistant HIV‐1: Endorsed by the American Academy of HIV Medicine, American College of Clinical Pharmacy

Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, Volume 44, Issue 5, Page 360-382, May 2024.
Abstract Treatment options are currently limited for persons with HIV‐1 (PWH) who are heavily treatment‐experienced and/or have multidrug‐resistant HIV‐1. Three agents have been approved by the U.S. Food and Drug Administration (FDA) since 2018, representing a significant advancement for this population: ibalizumab, fostemsavir, and lenacapavir ...
David B. Cluck, Daniel B. Chastain, Milena Murray, Spencer H. Durham, Elias B. Chahine, Caroline Derrick, Julie B. Dumond, E. Kelly Hester, Sarah B. Jeter, Melissa D. Johnson, Christin Kilcrease, Wesley D. Kufel, Jeffrey Kwong, Amber F. Ladak, Nimish Patel, Sarah E. Pérez, Jonell B. Poe, Charlotte Bolch, Ian Thomas, Elizabeth Asiago‐Reddy, William R. Short   +20 more
wiley   +1 more source

Drug interactions between non-rifamycin antibiotics and hormonal contraception: a systematic review [PDF]

, 2018
ObjectiveTo determine whether interactions between non-rifamycin antibiotics and hormonal contraceptives result in decreased effectiveness or increased toxicity of either therapy.Data sourcesWe searched MEDLINE, Embase, clinicaltrials.gov and Cochrane ...
Curtis, Kathryn M., Haddad, Lisa B., Nanda, Kavita, Simmons, Katharine B.   +3 more
core   +2 more sources

Sphingosine 1‐phosphate receptor modulators in multiple sclerosis treatment: A practical review

Annals of Clinical and Translational Neurology, Volume 11, Issue 4, Page 842-855, April 2024.
Abstract Four sphingosine 1‐phosphate (S1P) receptor modulators (fingolimod, ozanimod, ponesimod, and siponimod) are approved by the US Food and Drug Administration for the treatment of multiple sclerosis. This review summarizes efficacy and safety data on these S1P receptor modulators, with an emphasis on similarities and differences.
Patricia K. Coyle, Mark S. Freedman, Bruce A. Cohen, Bruce A. C. Cree, Clyde E. Markowitz   +4 more
wiley   +1 more source

In Vivo and In Vitro Action of Norethindrone on Staphylococci [PDF]

Journal of Bacteriology, 1967
Norethindrone has been examined in vitro for antibacterial activity against 10 microorganisms. Turbidimetric techniques were used to assay the antibacterial activity of norethindrone. The organisms tested included Staphylococcus aureus, S.
openaire   +3 more sources

“Conceiving” the pill : the 45th birthday of the oral contraceptive pill in Europe [PDF]

, 2006
In 1961, the first combined oral contraceptive pill was introduced in Europe. This pill contained ethinylestradiol (0.05mg) and northisterone (4mg). Nowadays, monophasic pill preparations contain a low dose (20­35 g) of ethinylestradiol in combination ...
Brincat, Mark P., Calleja-Agius, Jean
core  

A RAPID STABILITY INDICATING HPLC-METHOD FOR DETERMINATION OF NORETHISTERONE ACETATE IN PLASMA, TABLETS AND IN A MIXTURE WITH OTHER STEROIDS [PDF]

, 2015
Objectives: This study reports about a simple, rapid and accurate, routine-HPLC method for quantification of Norethisterone acetate (NA) in bulk powder, tablets and plasma.Methods: The chromatographic separation is carried out using isocratic binary ...
Abd El-hay, Soad, Hashem, Hisham, Jira, Thomas   +2 more
core   +1 more source

Cell Surface-Binding Sites for Progesterone Mediate Calcium Uptake in Human Sperm [PDF]

, 1991
Recent studies (e.g. Blackmore, P. F., Beebe, S. J., Danforth, D. R., and Alexander, N.) (1990) J. Biol. Chem. 265, 1376-1380) have shown that in human sperm, progesterone produces a rapid increase in intracellular free calcium ([Ca2+]i) and an induction
Beebe, Stephen J., Blackmore, Peter F., Lattanzio, Frank, Neulan, Joseph   +3 more
core   +1 more source